The Canadian Diabetes Association has released the 2008 edition of the clinical practice guidelines for the prevention and management of diabetes in Canada.
Santhera Pharmaceuticals is introducing Catena for the symptomatic management of patients with Friedreich's ataxia, which is a rare, progressive neuromuscular disease.